Celox is a chitosan-based haemostatic agent for controlling moderate to severe traumatic bleeding. The chitosan granules activate on contact with blood, forming a gel-like clot that seals the wound independently of the body's normal clotting cascade. Celox is non-exothermic - it does not generate heat during activation - distinguishing it from some alternative haemostatic agents. Proven in military and civilian trauma applications worldwide.
Compliance Summary: Celox is a medical device using chitosan haemostatic technology. The non-exothermic activation profile means Celox does not generate heat during clot formation, reducing the risk of thermal tissue damage at the wound site. Celox is used by military forces and civilian emergency services internationally.
What does non-exothermic mean?
Non-exothermic means the product does not generate heat during its haemostatic reaction. Some older haemostatic agents produced significant heat when activated by blood, which could cause thermal burns to already damaged tissue. Celox activates without heat generation, making it safer for use in wound cavities and on sensitive tissue.
Can Celox work on patients taking blood thinners?
Yes. Celox works independently of the body's normal clotting factors, meaning it remains effective on patients taking anticoagulant medication such as warfarin or heparin. The chitosan forms a mechanical clot by binding directly to red blood cells, bypassing the coagulation cascade that blood thinners suppress.